Anika Therapeutics | ANIK - Equity Capital And Reserves


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Anika Therapeutics

Anika Therapeutics reported $277.59M in Equity Capital and Reserves for its fiscal quarter ending in March of 2023.


Equity Capital And Reserves Change
Abbott ABT:US USD 37.01B 324M
Acorda Therapeutics ACOR:US USD 76.96M 16.66M
Agenus AGEN:US USD -58536000 2.74M
Agios Pharmaceuticals AGIO:US USD 1.04B 64.29M
Anika Therapeutics ANIK:US USD 277.59M 7.98M
Arrowhead Research ARWR:US USD 446.77M 69.73M
Enanta Pharmaceuticals ENTA:US USD 269.38M 31.46M
Halozyme Therapeutics HALO:US USD 65.85M 103.95M
Heron Therapeutics HRTX:US USD -11429000 25M
Immunogen IMGN:US USD 121.92M 33.91M
Insmed INSM:US USD -44653000 132.6M
Integra LifeSciences IART:US USD 1.67B 129.46M
Intrexon XON:US USD 184.13M 57.87M
J&J JNJ:US USD 70.87B 5.94B
Karyopharm Therapeutics KPTI:US USD -45174000 28.52M
Ligand Pharmaceuticals LGND:US USD 646.32M 48.83M
MacroGenics MGNX:US USD 109.27M 32.74M
Merit Medical Systems MMSI:US USD 1.17B 27.26M
Peregrine Pharmaceuticals PPHM:US USD 185.4M 4.2M
Rigel Pharmaceuticals RIGL:US USD -24257000 10.64M
Sangamo BioSciences SGMO:US USD 335.61M 40.65M
Smith & Nephew PLC SN/:LN USD 5.26B 136M
Stryker SYK:US USD 16.9B 279M
Surmodics SRDX:US USD 102.55M 4.71M
Veracyte VCYT:US USD 1.08B 6.06M
Xencor XNCR:US USD 683.58M 43.91M
Zimmer Biomet Holdings Inc ZBH:US USD 12.16B 137.3M